My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 432

    1.

    Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats.

    Turnbull AV, Ellershaw L, Masters DJ, Birtles S, Boyer S, Carroll D, Clarkson P, Loxham SJ, McAulay P, Teague JL, Foote KM, Pease JE, Block MH.

    Diabetes. 2002 Aug;51(8):2441-9.PMID: 12145156 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides.

    Schaffhauser AO, Stricker-Krongrad A, Brunner L, Cumin F, Gerald C, Whitebread S, Criscione L, Hofbauer KG.

    Diabetes. 1997 Nov;46(11):1792-8.PMID: 9356028 [PubMed - indexed for MEDLINE]Related articles

    3.

    The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.

    Kanatani A, Kanno T, Ishihara A, Hata M, Sakuraba A, Tanaka T, Tsuchiya Y, Mase T, Fukuroda T, Fukami T, Ihara M.

    Biochem Biophys Res Commun. 1999 Dec 9;266(1):88-91.PMID: 10581170 [PubMed - indexed for MEDLINE]Related articles

    4.

    Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.

    Raposinho PD, Broqua P, Pierroz DD, Hayward A, Dumont Y, Quirion R, Junien JL, Aubert ML.

    Endocrinology. 1999 Sep;140(9):4046-55.PMID: 10465275 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.

    Kask A, Rägo L, Harro J.

    Br J Pharmacol. 1998 Aug;124(7):1507-15.PMID: 9723965 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A typical Y1 receptor regulates feeding behaviors: effects of a potent and selective Y1 antagonist, J-115814.

    Kanatani A, Hata M, Mashiko S, Ishihara A, Okamoto O, Haga Y, Ohe T, Kanno T, Murai N, Ishii Y, Fukuroda T, Fukami T, Ihara M.

    Mol Pharmacol. 2001 Mar;59(3):501-5.PMID: 11179445 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.

    Kanatani A, Ishihara A, Iwaasa H, Nakamura K, Okamoto O, Hidaka M, Ito J, Fukuroda T, MacNeil DJ, Van der Ploeg LH, Ishii Y, Okabe T, Fukami T, Ihara M.

    Biochem Biophys Res Commun. 2000 May 27;272(1):169-73.PMID: 10872822 [PubMed - indexed for MEDLINE]Related articles

    8.

    Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for neuropeptide Y Y5 receptor.

    Kakui N, Tanaka J, Tabata Y, Asai K, Masuda N, Miyara T, Nakatani Y, Ohsawa F, Nishikawa N, Sugai M, Suzuki M, Aoki K, Kitaguchi H.

    J Pharmacol Exp Ther. 2006 May;317(2):562-70. Epub 2006 Jan 25.PMID: 16436501 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Stimulation of feeding in lean but not in obese Zucker rats by a selective neuropeptide Y Y5 receptor agonist.

    Wyss P, Levens N, Stricker-Krongrad A.

    Neuroreport. 1998 Aug 3;9(11):2675-7.PMID: 9721954 [PubMed - indexed for MEDLINE]Related articles

    10.

    Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.

    Silva AP, Carvalho AP, Carvalho CM, Malva JO.

    Neuropharmacology. 2003 Feb;44(2):282-92.PMID: 12623227 [PubMed - indexed for MEDLINE]Related articles

    11.

    Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.

    Kanatani A, Mashiko S, Murai N, Sugimoto N, Ito J, Fukuroda T, Fukami T, Morin N, MacNeil DJ, Van der Ploeg LH, Saga Y, Nishimura S, Ihara M.

    Endocrinology. 2000 Mar;141(3):1011-6.PMID: 10698177 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptor.

    Della-Zuana O, Revereault L, Beck-Sickinger A, Monge A, Caignard DH, Fauchère JL, Henlin JM, Audinot V, Boutin JA, Chamorro S, Félétou M, Levens N.

    Int J Obes Relat Metab Disord. 2004 Apr;28(4):628-39.PMID: 14758341 [PubMed - indexed for MEDLINE]Related articles

    13.

    Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade.

    Della Zuana O, Sadlo M, Germain M, Félétou M, Chamorro S, Tisserand F, de Montrion C, Boivin JF, Duhault J, Boutin JA, Levens N.

    Int J Obes Relat Metab Disord. 2001 Jan;25(1):84-94.PMID: 11244462 [PubMed - indexed for MEDLINE]Related articles

    14.

    Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?

    Haynes AC, Arch JR, Wilson S, McClue S, Buckingham RE.

    Regul Pept. 1998 Sep 25;75-76:355-61.PMID: 9802429 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of neuropeptide Y on food intake and brain biogenic amines in the rainbow trout (Oncorhynchus mykiss).

    Aldegunde M, Mancebo M.

    Peptides. 2006 Apr;27(4):719-27. Epub 2005 Oct 25.PMID: 16253390 [PubMed - indexed for MEDLINE]Related articles

    16.

    Feeding response to neuropeptide Y-related compounds in rats treated with Y5 receptor antisense or sense phosphothio-oligodeoxynucleotide.

    Flynn MC, Turrin NP, Plata-Salamán CR, Ffrench-Mullen JM.

    Physiol Behav. 1999 Jul;66(5):881-4.PMID: 10405118 [PubMed - indexed for MEDLINE]Related articles

    17.

    Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY.

    Mashiko S, Ishihara A, Iwaasa H, Sano H, Oda Z, Ito J, Yumoto M, Okawa M, Suzuki J, Fukuroda T, Jitsuoka M, Morin NR, MacNeil DJ, Van der Ploeg LH, Ihara M, Fukami T, Kanatani A.

    Endocrinology. 2003 May;144(5):1793-801.PMID: 12697685 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Responsiveness of obese Zucker rats to [D-Trp34]-NPY supports the targeting of Y5 receptor for obesity treatment.

    Beck B, Richy S, Stricker-Krongrad A.

    Nutr Neurosci. 2007 Oct-Dec;10(5-6):211-4.PMID: 18284029 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.

    Antal-Zimanyi I, Bruce MA, Leboulluec KL, Iben LG, Mattson GK, McGovern RT, Hogan JB, Leahy CL, Flowers SC, Stanley JA, Ortiz AA, Poindexter GS.

    Eur J Pharmacol. 2008 Aug 20;590(1-3):224-32. Epub 2008 Jun 12.PMID: 18573246 [PubMed - indexed for MEDLINE]Related articles

    20.

    Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.

    Sørensen G, Lindberg C, Wörtwein G, Bolwig TG, Woldbye DP.

    J Neurosci Res. 2004 Sep 1;77(5):723-9.PMID: 15352219 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity